US Stock MarketDetailed Quotes

PharmaCyte Biotech (PMCB)

Watchlist
  • 0.6813
  • +0.0002+0.03%
Close Apr 8 16:00 ET
7.31MMarket Cap-0.77P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PharmaCyte Biotech (PMCB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2026
(Q2)Oct 31, 2025
(Q1)Jul 31, 2025
(FY)Apr 30, 2025
(Q4)Apr 30, 2025
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
120.58%2.12M
24.41%1.38M
-33.15%848.31K
-32.85%4.38M
-10.66%1.04M
-48.62%960.25K
-21.53%1.11M
-38.86%1.27M
1.00%6.52M
29.11%1.17M
Selling and administrative expenses
140.48%2.02M
22.44%1.23M
-35.79%753.15K
-35.55%3.94M
-57.67%915.13K
-24.91%842.06K
-8.17%1.01M
-32.24%1.17M
28.63%6.11M
284.59%2.16M
-General and administrative expense
140.48%2.02M
22.44%1.23M
-35.79%753.15K
-35.55%3.94M
-57.67%915.13K
-24.91%842.06K
-8.17%1.01M
-32.24%1.17M
28.63%6.11M
284.59%2.16M
Research and development costs
-21.22%93.11K
44.75%141.09K
-0.89%95.16K
7.60%438.42K
34.56%126.73K
-6.74%118.2K
18.82%97.47K
-8.10%96.02K
-13.04%407.43K
9.68%94.18K
Other operating expenses
----
----
----
----
----
-62.49%232.86K
23.64%283.33K
62.29%389.48K
7.08%1.32M
-8.92%232.48K
Operating profit
-120.58%-2.12M
-24.41%-1.38M
33.15%-848.31K
32.85%-4.38M
10.66%-1.04M
48.62%-960.25K
21.53%-1.11M
38.86%-1.27M
-1.00%-6.52M
-29.11%-1.17M
Net non-operating interest income expense
-9.79%230.67K
-46.05%206.39K
-60.22%217.79K
-58.35%1.42M
-69.23%229.88K
-71.00%255.69K
-57.22%382.56K
-37.50%547.43K
75.42%3.4M
3.34%747.1K
Non-operating interest income
-9.79%230.67K
-46.05%206.39K
-60.22%217.79K
-58.35%1.42M
-69.23%229.88K
-71.00%255.69K
-57.22%382.56K
-37.50%547.43K
75.42%3.4M
3.34%747.1K
Other net income (expense)
212.54%2.63M
-737.51%-6.25M
-132.02%-7.73M
873.05%33.62M
611.37%12.56M
-736.52%-2.34M
-122.57%-746.06K
1,316.97%24.14M
1,610.36%3.45M
3,169.55%1.77M
Gain on sale of security
212.59%2.63M
-544.12%-4.8M
-132.45%-7.84M
421.33%35.64M
183.45%14.58M
-735.97%-2.34M
-122.53%-745K
1,318.11%24.14M
--6.84M
--5.14M
Special income (charges)
--0
--0
--106K
43.48%-2.02M
---2.02M
--0
--0
----
---3.57M
----
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--2M
----
-Less:Other special charges
----
----
---106K
--2.02M
----
----
----
----
----
----
-Write off
----
----
----
----
----
----
----
----
--1.57M
----
-Gain on sale of property,plant,equipment
----
----
----
--0
----
----
----
----
---1.57M
----
Other non- operating income (expenses)
-58.00%-632
-136,401.69%-1.45M
36.32%-121
-100.50%-965
-100.06%-113
-58.10%-400
-38.82%-1.06K
89.72%-190
-5.37%191.15K
259.23%194.01K
Income before tax
124.52%746.86K
-404.78%-7.42M
-135.69%-8.36M
9,084.98%30.66M
772.47%11.75M
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
107.73%333.76K
1,165.95%1.35M
Income tax
Net income
124.52%746.86K
-404.78%-7.42M
-135.69%-8.36M
9,084.98%30.66M
772.47%11.75M
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
107.73%333.76K
1,165.95%1.35M
Net income continuous Operations
124.52%746.86K
-404.78%-7.42M
-135.69%-8.36M
9,084.98%30.66M
772.47%11.75M
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
107.73%333.76K
1,165.95%1.35M
Minority interest income
Net income attributable to the parent company
124.52%746.86K
-404.78%-7.42M
-135.69%-8.36M
9,084.98%30.66M
772.47%11.75M
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
107.73%333.76K
1,165.95%1.35M
Preferred stock dividends
98.46K
-78.23%96.64K
-55.13%1.13M
0
-24.35%443.96K
114.41%685.8K
2.52M
829.4K
Other preferred stock dividends
2.2M
-13.71%902K
0
-59.05%6.16M
-2.85%2.97M
0
-76.57%1.05M
-34.35%2.15M
15.05M
3.06M
Net income attributable to common stockholders
48.90%-1.56M
-184.45%-8.42M
-140.61%-8.36M
235.53%23.36M
445.55%8.78M
45.81%-3.05M
-31.03%-2.96M
403.87%20.59M
-299.38%-17.24M
-1,910.91%-2.54M
Basic earnings per share
61.36%-0.17
-217.95%-1.24
-164.74%-1.23
277.22%3.19
560.61%1.52
32.31%-0.44
-50.00%-0.39
451.85%1.9
-718.18%-1.8
-3,200.00%-0.33
Diluted earnings per share
61.36%-0.17
-217.95%-1.24
-164.74%-1.23
277.22%3.19
560.61%1.52
32.31%-0.44
-50.00%-0.39
451.85%1.9
-718.18%-1.8
-3,200.00%-0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Jan 31, 2026(Q2)Oct 31, 2025(Q1)Jul 31, 2025(FY)Apr 30, 2025(Q4)Apr 30, 2025(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 120.58%2.12M24.41%1.38M-33.15%848.31K-32.85%4.38M-10.66%1.04M-48.62%960.25K-21.53%1.11M-38.86%1.27M1.00%6.52M29.11%1.17M
Selling and administrative expenses 140.48%2.02M22.44%1.23M-35.79%753.15K-35.55%3.94M-57.67%915.13K-24.91%842.06K-8.17%1.01M-32.24%1.17M28.63%6.11M284.59%2.16M
-General and administrative expense 140.48%2.02M22.44%1.23M-35.79%753.15K-35.55%3.94M-57.67%915.13K-24.91%842.06K-8.17%1.01M-32.24%1.17M28.63%6.11M284.59%2.16M
Research and development costs -21.22%93.11K44.75%141.09K-0.89%95.16K7.60%438.42K34.56%126.73K-6.74%118.2K18.82%97.47K-8.10%96.02K-13.04%407.43K9.68%94.18K
Other operating expenses ---------------------62.49%232.86K23.64%283.33K62.29%389.48K7.08%1.32M-8.92%232.48K
Operating profit -120.58%-2.12M-24.41%-1.38M33.15%-848.31K32.85%-4.38M10.66%-1.04M48.62%-960.25K21.53%-1.11M38.86%-1.27M-1.00%-6.52M-29.11%-1.17M
Net non-operating interest income expense -9.79%230.67K-46.05%206.39K-60.22%217.79K-58.35%1.42M-69.23%229.88K-71.00%255.69K-57.22%382.56K-37.50%547.43K75.42%3.4M3.34%747.1K
Non-operating interest income -9.79%230.67K-46.05%206.39K-60.22%217.79K-58.35%1.42M-69.23%229.88K-71.00%255.69K-57.22%382.56K-37.50%547.43K75.42%3.4M3.34%747.1K
Other net income (expense) 212.54%2.63M-737.51%-6.25M-132.02%-7.73M873.05%33.62M611.37%12.56M-736.52%-2.34M-122.57%-746.06K1,316.97%24.14M1,610.36%3.45M3,169.55%1.77M
Gain on sale of security 212.59%2.63M-544.12%-4.8M-132.45%-7.84M421.33%35.64M183.45%14.58M-735.97%-2.34M-122.53%-745K1,318.11%24.14M--6.84M--5.14M
Special income (charges) --0--0--106K43.48%-2.02M---2.02M--0--0-------3.57M----
-Less:Impairment of capital assets --------------0------------------2M----
-Less:Other special charges -----------106K--2.02M------------------------
-Write off ----------------------------------1.57M----
-Gain on sale of property,plant,equipment --------------0-------------------1.57M----
Other non- operating income (expenses) -58.00%-632-136,401.69%-1.45M36.32%-121-100.50%-965-100.06%-113-58.10%-400-38.82%-1.06K89.72%-190-5.37%191.15K259.23%194.01K
Income before tax 124.52%746.86K-404.78%-7.42M-135.69%-8.36M9,084.98%30.66M772.47%11.75M-391.55%-3.05M-152.67%-1.47M835.76%23.42M107.73%333.76K1,165.95%1.35M
Income tax
Net income 124.52%746.86K-404.78%-7.42M-135.69%-8.36M9,084.98%30.66M772.47%11.75M-391.55%-3.05M-152.67%-1.47M835.76%23.42M107.73%333.76K1,165.95%1.35M
Net income continuous Operations 124.52%746.86K-404.78%-7.42M-135.69%-8.36M9,084.98%30.66M772.47%11.75M-391.55%-3.05M-152.67%-1.47M835.76%23.42M107.73%333.76K1,165.95%1.35M
Minority interest income
Net income attributable to the parent company 124.52%746.86K-404.78%-7.42M-135.69%-8.36M9,084.98%30.66M772.47%11.75M-391.55%-3.05M-152.67%-1.47M835.76%23.42M107.73%333.76K1,165.95%1.35M
Preferred stock dividends 98.46K-78.23%96.64K-55.13%1.13M0-24.35%443.96K114.41%685.8K2.52M829.4K
Other preferred stock dividends 2.2M-13.71%902K0-59.05%6.16M-2.85%2.97M0-76.57%1.05M-34.35%2.15M15.05M3.06M
Net income attributable to common stockholders 48.90%-1.56M-184.45%-8.42M-140.61%-8.36M235.53%23.36M445.55%8.78M45.81%-3.05M-31.03%-2.96M403.87%20.59M-299.38%-17.24M-1,910.91%-2.54M
Basic earnings per share 61.36%-0.17-217.95%-1.24-164.74%-1.23277.22%3.19560.61%1.5232.31%-0.44-50.00%-0.39451.85%1.9-718.18%-1.8-3,200.00%-0.33
Diluted earnings per share 61.36%-0.17-217.95%-1.24-164.74%-1.23277.22%3.19560.61%1.5232.31%-0.44-50.00%-0.39451.85%1.9-718.18%-1.8-3,200.00%-0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -